Related Experiment Video
Updated: Aug 27, 2025

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts
Maxime R F Gosselin1, Virginie Mournetas2, Malgorzata Borczyk3
1School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
Abstract:
Duchenne muscular dystrophy (DMD) affects myofibers and muscle stem cells, causing progressive muscle degeneration and repair defects. It was unknown whether dystrophic myoblasts-the effector cells of muscle growth and regeneration-are affected. Using transcriptomic, genome-scale metabolic modelling and functional analyses, we demonstrate, for the first time, convergent abnormalities in primary mouse and human dystrophic myoblasts. In Dmdmdx myoblasts lacking full-length dystrophin, the expression of 170 genes was significantly altered. Myod1 and key genes controlled by MyoD (Myog, Mymk, Mymx, epigenetic regulators, ECM interactors, calcium signalling and fibrosis genes) were significantly downregulated. Gene ontology analysis indicated enrichment in genes involved in muscle development and function. Functionally, we found increased myoblast proliferation, reduced chemotaxis and accelerated differentiation, which are all essential for myoregeneration. The defects were caused by the loss of expression of full-length dystrophin, as similar and not exacerbated alterations were observed in dystrophin-null Dmdmdx-βgeo myoblasts. Corresponding abnormalities were identified in human DMD primary myoblasts and a dystrophic mouse muscle cell line, confirming the cross-species and cell-autonomous nature of these defects. The genome-scale metabolic analysis in human DMD myoblasts showed alterations in the rate of glycolysis/gluconeogenesis, leukotriene metabolism, and mitochondrial beta-oxidation of various fatty acids. These results reveal the disease continuum: DMD defects in satellite cells, the myoblast dysfunction affecting muscle regeneration, which is insufficient to counteract muscle loss due to myofiber instability. Contrary to the established belief, our data demonstrate that DMD abnormalities occur in myoblasts, making these cells a novel therapeutic target for the treatment of this lethal disease.
Insights
Duchenne muscular dystrophy (DMD) causes muscle degeneration by affecting myoblasts, the cells responsible for muscle growth and repair. These dystrophin-deficient cells exhibit abnormal gene expression and function, revealing them as a new therapeutic target.
Area of Science:
- Muscle Biology
- Cellular and Molecular Medicine
- Regenerative Medicine
Background:
- Duchenne muscular dystrophy (DMD) is characterized by progressive muscle degeneration and impaired repair.
- The role of dystrophin-deficient myoblasts in DMD pathogenesis was previously unclear.
- Myoblasts are crucial for muscle growth and regeneration.
Purpose of the Study:
- To investigate whether dystrophic myoblasts exhibit abnormalities.
- To identify molecular and functional defects in primary mouse and human DMD myoblasts.
- To explore myoblasts as a potential therapeutic target for DMD.
Main Methods:
- Transcriptomic analysis of dystrophic myoblasts.
- Genome-scale metabolic modeling.
- Functional assays including proliferation, chemotaxis, and differentiation.
- Cross-species comparison of mouse and human DMD myoblasts.
Main Results:
- Dystrophic myoblasts showed significant alterations in gene expression, including downregulation of MyoD-controlled genes essential for muscle development.
- Functional deficits included increased proliferation, reduced chemotaxis, and accelerated differentiation.
- Metabolic analysis revealed dysregulation in glycolysis, leukotriene metabolism, and fatty acid oxidation.
- Abnormalities were confirmed in both mouse and human DMD myoblasts, indicating cell-autonomous defects.
Conclusions:
- Duchenne muscular dystrophy affects myoblasts, leading to impaired muscle regeneration.
- These cell-autonomous defects in myoblasts contribute to the disease progression.
- Dystrophic myoblasts represent a novel therapeutic target for DMD treatment.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Abnormal Proliferation

